Buchumschlag

A Patient-Specific Digital Twin for Adaptive Radiotherapy of Non-Small Cell Lung Cancer

Fuente: arXiv

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sud, Anvi, Huang, Jialu, Hart, Gregory R., Saxena, Keshav, Kim, John, Tressel, Lauren, Deng, Jun
Format:	Preprint
Veröffentlicht:	2026
Schlagworte:	Computer Vision and Pattern Recognition
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Chemoimmunotherapy With or Without Thoracic Radiotherapy for Elderly Patients in Advanced Non‐Small Cell Lung Cancer
von: Zhiru Gao, et al.
Veröffentlicht: (2026)

Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence
von: Justin L. Burr, et al.
Veröffentlicht: (2024)

Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients
von: Minghe Lv, et al.
Veröffentlicht: (2024)

The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis
von: Qian Zeng, et al.
Veröffentlicht: (2024)

A Digital Twin Framework for Adaptive Treatment Planning in Radiotherapy
von: Chang, Chih-Wei, et al.
Veröffentlicht: (2025)

Survival in Immune Checkpoint Inhibitor–Treated Patients With Rheumatoid Arthritis and Non–Small Cell Lung Cancer: An Observational Cohort Study
von: Deanna P. Jannat‐Khah, et al.
Veröffentlicht: (2025)

ASPM Induces Radiotherapy Resistance by Disrupting Microtubule Stability Leading to Chromosome Malsegregation in Non‐Small Cell Lung Cancer
von: Tao Zhong, et al.
Veröffentlicht: (2025)

Predictive Digital Twin for Optimizing Patient-Specific Radiotherapy Regimens under Uncertainty in High-Grade Gliomas
von: Chaudhuri, Anirban, et al.
Veröffentlicht: (2023)

Long‐Term Outcomes and Toxicities in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens
von: Meghana Maddula, et al.
Veröffentlicht: (2025)

Programmed Death‐Ligand 1 Expression Predicts Poor Prognosis in Patients With Early‐Stage Non‐Small‐Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy
von: Jongmoo Park, et al.
Veröffentlicht: (2026)

Expression of NUF2 and CD52 and Their Correlation With Chemotherapy Resistance and Prognosis in Patients With Non‐Small Cell Lung Cancer
von: Jun Han, et al.
Veröffentlicht: (2025)

Pembrolizumab‐Induced Chronic Rhinosinusitis in a Patient With Non‐Small Cell Lung Cancer
von: Yuji Yamasaki, et al.
Veröffentlicht: (2025)

Comparison of Survival Outcomes of Early‐Stage Non‐Small‐Cell Lung Cancer in Elderly Patients (≥ 70 years) Treated With Stereotactic Body Radiotherapy Versus Surgical Resection
von: Guo‐jun Wu, et al.
Veröffentlicht: (2025)

Population Pharmacokinetics and Exposure‐Response of Subcutaneous Atezolizumab in Patients With Non‐Small Cell Lung Cancer
von: Phyllis Chan, et al.
Veröffentlicht: (2025)

Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non–Small Cell Lung Cancer
von: Hayato Yokota, et al.
Veröffentlicht: (2026)

The Efficacy and Safety of Brain Radiotherapy Combined With Immune Checkpoint Inhibitors (ICIs) for Small‐Cell Lung Cancer (SCLC) Patients With Brain Metastases (BMs)
von: Jie Xu, et al.
Veröffentlicht: (2025)

The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study
von: Lipin Liu, et al.
Veröffentlicht: (2024)

FOXA1‐NAT10 Positive Feedback Pathway Promotes Non‐Small Cell Lung Cancer Cell Progression
von: Anqing Zhu, et al.
Veröffentlicht: (2025)

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review
von: Lauren Julia Brown, et al.
Veröffentlicht: (2025)

Chromosomal Instability Identifies High‐Risk Patients With Early‐Stage Non‐Small Cell Lung Cancer
von: Mobina Shrestha, et al.
Veröffentlicht: (2026)

Cutaneous Toxicities Associated With Amivantamab in Patients With Non‐Small Cell Lung Cancer: A Systematic Review
von: Ioannis‐Alexios Koumprentziotis, et al.
Veröffentlicht: (2026)

Tepotinib‐Induced Cholangitis in a Patient With Non‐Small Cell Lung Cancer: A Case Report
von: Yoshimasa Hachisu, et al.
Veröffentlicht: (2025)

Association Between Area‐Level Socioeconomic Disadvantage and Immunotherapy in Patients With Non‐Small Cell Lung Cancer
von: Hiroe Suzuki‐Chiba, et al.
Veröffentlicht: (2025)

Automatic Cough Analysis for Non-Small Cell Lung Cancer Detection
von: Giangregorio, Chiara, et al.
Veröffentlicht: (2025)

Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care
von: Safraz A. Hamid, et al.
Veröffentlicht: (2025)

Pseudocellulitis in the Setting of Pemetrexed Treatment for Non‐Small Cell Lung Cancer
von: Cassidy M. Nguyen, et al.
Veröffentlicht: (2025)

Nanomedicine in Immunotherapy for Non‐Small Cell Lung Cancer: Applications and Perspectives
von: Shuangsi Liao, et al.
Veröffentlicht: (2025)

Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2
von: Yongzheng Yao, et al.
Veröffentlicht: (2025)

Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer
von: Min Woo Kim, et al.
Veröffentlicht: (2024)

Predicting Targeted Therapy Resistance in Non-Small Cell Lung Cancer Using Multimodal Machine Learning
von: Hua, Peiying, et al.
Veröffentlicht: (2025)

NFAT5 Regulates IL8 to Promote Cell Growth and Migration in Non‐Small Cell Lung Cancer
von: Jinliang Chen, et al.
Veröffentlicht: (2025)

Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
von: Yuko Iida, et al.
Veröffentlicht: (2026)

Best Practices for the Multidisciplinary Care of Patients With Early‐Stage Driver‐Mutated Non‐Small Cell Lung Cancer
von: Joshua Sabari, et al.
Veröffentlicht: (2026)

Desensitizing Effect of Intra‐Tumoral GDF‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer
von: Naoya Nishioka, et al.
Veröffentlicht: (2025)

Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer
von: Guoqing Lyu, et al.
Veröffentlicht: (2025)

Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers
von: Jinjing Tan, et al.
Veröffentlicht: (2025)

Pleuritis Induced by Brigatinib During the Treatment of Non‐Small Cell Lung Cancer
von: Shohei Yano, et al.
Veröffentlicht: (2026)

Pyroptosis‐Mediated Antitumor Activity of Cinobufagin in Non‐Small Cell Lung Cancer
von: Ying Chen, et al.
Veröffentlicht: (2025)

Is Chest Wall Resection Safe in Geriatric Non‐Small Cell Lung Cancer?
von: Ozkan Saydam, et al.
Veröffentlicht: (2025)

Chronological Effects of Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
von: Xinyue Guo, et al.
Veröffentlicht: (2025)